APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Valsartan Drug Market Analysis and Forecast 2026-2032

20 December 2025201 pages

Choose your research edition.

Industry ResearchValsartan Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Valsartan Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Drug Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Drug Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Valsartan Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Valsartan Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Valsartan Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Valsartan Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Valsartan Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Valsartan Drug include Zhejiang Huahai Pharmaceutical, Teva, Sun Pharmaceutical, Novartis, Mylan, Huaren Pharmaceutical, Unichem Laboratories, Torrent Pharmaceuticals and Square Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Valsartan Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Valsartan Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Valsartan Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Valsartan Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Valsartan Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Valsartan Drug sales, projected growth trends, production technology, application and end-user industry.

Valsartan Drug Segment by Company

Zhejiang Huahai Pharmaceutical

Teva

Sun Pharmaceutical

Novartis

Mylan

Huaren Pharmaceutical

Unichem Laboratories

Torrent Pharmaceuticals

Square Pharmaceuticals

Macleods Pharmaceuticals

Lupin

Jubilant Pharma

HETERO

Aurobindo Pharma

Amneal Pharmaceuticals

Alembic Pharmaceuticals

Valsartan Drug Segment by Type

40 mg Tablets

80 mg Tablets

160 mg Tablets

320 mg Tablets

Valsartan Drug Segment by Application

Heart Failure

Heart Attack

Hypertension

Valsartan Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Valsartan Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Valsartan Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valsartan Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Valsartan Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 40 mg Tablets Major Manufacturers Table 3. 80 mg Tablets Major Manufacturers Table 4. 160 mg Tablets Major Manufacturers Table 5. 320 mg Tablets Major Manufacturers Table 6. Global Valsartan Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Heart Failure Major Manufacturers Table 8. Heart Attack Major Manufacturers Table 9. Hypertension Major Manufacturers Table 10. Valsartan Drug Industry Trends Table 11. Valsartan Drug Industry Drivers Table 12. Valsartan Drug Industry Opportunities and Challenges Table 13. Valsartan Drug Industry Restraints Table 14. Global Valsartan Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Valsartan Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Valsartan Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Valsartan Drug Revenue Market Share by Region (2021-2026) Table 18. Global Valsartan Drug Revenue Market Share by Region (2027-2032) Table 19. Global Valsartan Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 20. Global Valsartan Drug Sales by Region (2021-2026) & (W Units) Table 21. Global Valsartan Drug Sales by Region (2027-2032) & (W Units) Table 22. Global Valsartan Drug Sales Market Share by Region (2021-2026) Table 23. Global Valsartan Drug Sales Market Share by Region (2027-2032) Table 24. Global Valsartan Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Valsartan Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Valsartan Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Valsartan Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global Valsartan Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Valsartan Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Valsartan Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Valsartan Drug Manufacturers, Product Type & Application Table 32. Global Valsartan Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Valsartan Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Valsartan Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Valsartan Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Valsartan Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Valsartan Drug Revenue Market Share by Type (2021-2026) Table 39. Global Valsartan Drug Revenue Market Share by Type (2027-2032) Table 40. Global Valsartan Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 41. Global Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 42. Global Valsartan Drug Sales by Type (2027-2032) & (W Units) Table 43. Global Valsartan Drug Sales Market Share by Type (2021-2026) Table 44. Global Valsartan Drug Sales Market Share by Type (2027-2032) Table 45. Global Valsartan Drug Price by Type (2021-2026) & (US$/Unit) Table 46. Global Valsartan Drug Price by Type (2027-2032) & (US$/Unit) Table 47. Global Valsartan Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Valsartan Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Valsartan Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Valsartan Drug Revenue Market Share by Application (2021-2026) Table 51. Global Valsartan Drug Revenue Market Share by Application (2027-2032) Table 52. Global Valsartan Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 53. Global Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 54. Global Valsartan Drug Sales by Application (2027-2032) & (W Units) Table 55. Global Valsartan Drug Sales Market Share by Application (2021-2026) Table 56. Global Valsartan Drug Sales Market Share by Application (2027-2032) Table 57. Global Valsartan Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Valsartan Drug Price by Application (2027-2032) & (US$/Unit) Table 59. Zhejiang Huahai Pharmaceutical Company Information Table 60. Zhejiang Huahai Pharmaceutical Business Overview Table 61. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolio Table 63. Zhejiang Huahai Pharmaceutical Recent Development Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Teva Valsartan Drug Product Portfolio Table 68. Teva Recent Development Table 69. Sun Pharmaceutical Company Information Table 70. Sun Pharmaceutical Business Overview Table 71. Sun Pharmaceutical Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sun Pharmaceutical Valsartan Drug Product Portfolio Table 73. Sun Pharmaceutical Recent Development Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novartis Valsartan Drug Product Portfolio Table 78. Novartis Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Mylan Valsartan Drug Product Portfolio Table 83. Mylan Recent Development Table 84. Huaren Pharmaceutical Company Information Table 85. Huaren Pharmaceutical Business Overview Table 86. Huaren Pharmaceutical Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Huaren Pharmaceutical Valsartan Drug Product Portfolio Table 88. Huaren Pharmaceutical Recent Development Table 89. Unichem Laboratories Company Information Table 90. Unichem Laboratories Business Overview Table 91. Unichem Laboratories Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Unichem Laboratories Valsartan Drug Product Portfolio Table 93. Unichem Laboratories Recent Development Table 94. Torrent Pharmaceuticals Company Information Table 95. Torrent Pharmaceuticals Business Overview Table 96. Torrent Pharmaceuticals Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Torrent Pharmaceuticals Valsartan Drug Product Portfolio Table 98. Torrent Pharmaceuticals Recent Development Table 99. Square Pharmaceuticals Company Information Table 100. Square Pharmaceuticals Business Overview Table 101. Square Pharmaceuticals Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Square Pharmaceuticals Valsartan Drug Product Portfolio Table 103. Square Pharmaceuticals Recent Development Table 104. Macleods Pharmaceuticals Company Information Table 105. Macleods Pharmaceuticals Business Overview Table 106. Macleods Pharmaceuticals Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Macleods Pharmaceuticals Valsartan Drug Product Portfolio Table 108. Macleods Pharmaceuticals Recent Development Table 109. Lupin Company Information Table 110. Lupin Business Overview Table 111. Lupin Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Lupin Valsartan Drug Product Portfolio Table 113. Lupin Recent Development Table 114. Jubilant Pharma Company Information Table 115. Jubilant Pharma Business Overview Table 116. Jubilant Pharma Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Jubilant Pharma Valsartan Drug Product Portfolio Table 118. Jubilant Pharma Recent Development Table 119. HETERO Company Information Table 120. HETERO Business Overview Table 121. HETERO Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. HETERO Valsartan Drug Product Portfolio Table 123. HETERO Recent Development Table 124. Aurobindo Pharma Company Information Table 125. Aurobindo Pharma Business Overview Table 126. Aurobindo Pharma Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Aurobindo Pharma Valsartan Drug Product Portfolio Table 128. Aurobindo Pharma Recent Development Table 129. Amneal Pharmaceuticals Company Information Table 130. Amneal Pharmaceuticals Business Overview Table 131. Amneal Pharmaceuticals Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Amneal Pharmaceuticals Valsartan Drug Product Portfolio Table 133. Amneal Pharmaceuticals Recent Development Table 134. Alembic Pharmaceuticals Company Information Table 135. Alembic Pharmaceuticals Business Overview Table 136. Alembic Pharmaceuticals Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Alembic Pharmaceuticals Valsartan Drug Product Portfolio Table 138. Alembic Pharmaceuticals Recent Development Table 139. North America Valsartan Drug Revenue by Type (2021-2026) & (US$ Million) Table 140. North America Valsartan Drug Revenue by Type (2027-2032) & (US$ Million) Table 141. North America Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 142. North America Valsartan Drug Sales by Type (2027-2032) & (W Units) Table 143. North America Valsartan Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 144. North America Valsartan Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 145. North America Valsartan Drug Revenue by Application (2021-2026) & (US$ Million) Table 146. North America Valsartan Drug Revenue by Application (2027-2032) & (US$ Million) Table 147. North America Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 148. North America Valsartan Drug Sales by Application (2027-2032) & (W Units) Table 149. North America Valsartan Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 150. North America Valsartan Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 151. North America Valsartan Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. North America Valsartan Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. North America Valsartan Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. North America Valsartan Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 155. North America Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 156. North America Valsartan Drug Sales by Country (2027-2032) & (W Units) Table 157. North America Valsartan Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 158. North America Valsartan Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 159. United States Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 160. Canada Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 161. Europe Valsartan Drug Revenue by Type (2021-2026) & (US$ Million) Table 162. Europe Valsartan Drug Revenue by Type (2027-2032) & (US$ Million) Table 163. Europe Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 164. Europe Valsartan Drug Sales by Type (2027-2032) & (W Units) Table 165. Europe Valsartan Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 166. Europe Valsartan Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 167. Europe Valsartan Drug Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Valsartan Drug Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 170. Europe Valsartan Drug Sales by Application (2027-2032) & (W Units) Table 171. Europe Valsartan Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 172. Europe Valsartan Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Europe Valsartan Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Europe Valsartan Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Europe Valsartan Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Europe Valsartan Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 177. Europe Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 178. Europe Valsartan Drug Sales by Country (2027-2032) & (W Units) Table 179. Europe Valsartan Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 180. Europe Valsartan Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Germany Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 182. France Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 183. U.K. Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 184. Italy Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 185. Netherlands Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 186. China Valsartan Drug Revenue by Type (2021-2026) & (US$ Million) Table 187. China Valsartan Drug Revenue by Type (2027-2032) & (US$ Million) Table 188. China Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 189. China Valsartan Drug Sales by Type (2027-2032) & (W Units) Table 190. China Valsartan Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 191. China Valsartan Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 192. China Valsartan Drug Revenue by Application (2021-2026) & (US$ Million) Table 193. China Valsartan Drug Revenue by Application (2027-2032) & (US$ Million) Table 194. China Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 195. China Valsartan Drug Sales by Application (2027-2032) & (W Units) Table 196. China Valsartan Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 197. China Valsartan Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 198. Asia Valsartan Drug Revenue by Type (2021-2026) & (US$ Million) Table 199. Asia Valsartan Drug Revenue by Type (2027-2032) & (US$ Million) Table 200. Asia Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 201. Asia Valsartan Drug Sales by Type (2027-2032) & (W Units) Table 202. Asia Valsartan Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 203. Asia Valsartan Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 204. Asia Valsartan Drug Revenue by Application (2021-2026) & (US$ Million) Table 205. Asia Valsartan Drug Revenue by Application (2027-2032) & (US$ Million) Table 206. Asia Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 207. Asia Valsartan Drug Sales by Application (2027-2032) & (W Units) Table 208. Asia Valsartan Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 209. Asia Valsartan Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 210. Asia Valsartan Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. Asia Valsartan Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. Asia Valsartan Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. Asia Valsartan Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 214. Asia Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 215. Asia Valsartan Drug Sales by Country (2027-2032) & (W Units) Table 216. Asia Valsartan Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 217. Asia Valsartan Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 218. Japan Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 219. South Korea Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 220. India Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 221. Australia Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 222. China Taiwan Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 223. Southeast Asia Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 224. SAMEA Valsartan Drug Revenue by Type (2021-2026) & (US$ Million) Table 225. SAMEA Valsartan Drug Revenue by Type (2027-2032) & (US$ Million) Table 226. SAMEA Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 227. SAMEA Valsartan Drug Sales by Type (2027-2032) & (W Units) Table 228. SAMEA Valsartan Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 229. SAMEA Valsartan Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 230. SAMEA Valsartan Drug Revenue by Application (2021-2026) & (US$ Million) Table 231. SAMEA Valsartan Drug Revenue by Application (2027-2032) & (US$ Million) Table 232. SAMEA Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 233. SAMEA Valsartan Drug Sales by Application (2027-2032) & (W Units) Table 234. SAMEA Valsartan Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 235. SAMEA Valsartan Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 236. SAMEA Valsartan Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 237. SAMEA Valsartan Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 238. SAMEA Valsartan Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 239. SAMEA Valsartan Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 240. SAMEA Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 241. SAMEA Valsartan Drug Sales by Country (2027-2032) & (W Units) Table 242. SAMEA Valsartan Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 243. SAMEA Valsartan Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 244. Brazil Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 245. Argentina Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 246. Chile Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 247. Colombia Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 248. Peru Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 249. Saudi Arabia Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 250. Israel Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 251. UAE Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 252. Turkey Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 253. Iran Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 254. Egypt Valsartan Drug Revenue (2021-2032) & (US$ Million) Table 255. Key Raw Materials Table 256. Raw Materials Key Suppliers Table 257. Valsartan Drug Distributors List Table 258. Valsartan Drug Customers List Table 259. Research Programs/Design for This Report Table 260. Authors List of This Report Table 261. Secondary Sources Table 262. Primary Sources List of Figures Figure 1. Valsartan Drug Image Figure 2. Global Valsartan Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. 40 mg Tablets Image Figure 5. 80 mg Tablets Image Figure 6. 160 mg Tablets Image Figure 7. 320 mg Tablets Image Figure 8. Global Valsartan Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Valsartan Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Heart Failure Image Figure 11. Heart Attack Image Figure 12. Hypertension Image Figure 13. Global Valsartan Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Valsartan Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global Valsartan Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Valsartan Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Valsartan Drug Revenue Market Share by Region (2021-2032) Figure 18. Global Valsartan Drug Sales (2021-2032) & (W Units) Figure 19. Global Valsartan Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 20. Global Valsartan Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Valsartan Drug Sales YoY (2021-2032) & (W Units) Figure 22. Europe Valsartan Drug Sales YoY (2021-2032) & (W Units) Figure 23. China Valsartan Drug Sales YoY (2021-2032) & (W Units) Figure 24. Asia (Excluding China) Valsartan Drug Sales YoY (2021-2032) & (W Units) Figure 25. South America, Middle East and Africa Valsartan Drug Sales YoY (2021-2032) & (W Units) Figure 26. Global Valsartan Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Valsartan Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Valsartan Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Valsartan Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Valsartan Drug Revenue Market Share by Type (2021-2032) Figure 32. Global Valsartan Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 33. Global Valsartan Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Valsartan Drug Sales Market Share by Type (2021-2032) Figure 35. Global Valsartan Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Valsartan Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Valsartan Drug Revenue Market Share by Application (2021-2032) Figure 38. Global Valsartan Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 39. Global Valsartan Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Valsartan Drug Sales Market Share by Application (2021-2032) Figure 41. North America Valsartan Drug Revenue Share by Type (2021-2032) Figure 42. North America Valsartan Drug Sales Share by Type (2021-2032) Figure 43. North America Valsartan Drug Revenue Share by Application (2021-2032) Figure 44. North America Valsartan Drug Sales Share by Application (2021-2032) Figure 45. North America Valsartan Drug Revenue Share by Country (2021-2032) Figure 46. North America Valsartan Drug Sales Share by Country (2021-2032) Figure 47. Europe Valsartan Drug Revenue Share by Type (2021-2032) Figure 48. Europe Valsartan Drug Sales Share by Type (2021-2032) Figure 49. Europe Valsartan Drug Revenue Share by Application (2021-2032) Figure 50. Europe Valsartan Drug Sales Share by Application (2021-2032) Figure 51. Europe Valsartan Drug Revenue Share by Country (2021-2032) Figure 52. Europe Valsartan Drug Sales Share by Country (2021-2032) Figure 53. China Valsartan Drug Revenue Share by Type (2021-2032) Figure 54. China Valsartan Drug Sales Share by Type (2021-2032) Figure 55. China Valsartan Drug Revenue Share by Application (2021-2032) Figure 56. China Valsartan Drug Sales Share by Application (2021-2032) Figure 57. Asia Valsartan Drug Revenue Share by Type (2021-2032) Figure 58. Asia Valsartan Drug Sales Share by Type (2021-2032) Figure 59. Asia Valsartan Drug Revenue Share by Application (2021-2032) Figure 60. Asia Valsartan Drug Sales Share by Application (2021-2032) Figure 61. Asia Valsartan Drug Revenue Share by Country (2021-2032) Figure 62. Asia Valsartan Drug Sales Share by Country (2021-2032) Figure 63. SAMEA Valsartan Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA Valsartan Drug Sales Share by Type (2021-2032) Figure 65. SAMEA Valsartan Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Valsartan Drug Sales Share by Application (2021-2032) Figure 67. SAMEA Valsartan Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA Valsartan Drug Sales Share by Country (2021-2032) Figure 69. Valsartan Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Valsartan Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 40 mg Tablets
  • 80 mg Tablets
  • 160 mg Tablets
  • 320 mg Tablets
Applications
  • Heart Failure
  • Heart Attack
  • Hypertension
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva
  • Sun Pharmaceutical
  • Novartis
  • Mylan
  • Huaren Pharmaceutical
  • Unichem Laboratories
  • Torrent Pharmaceuticals
  • Square Pharmaceuticals
  • Macleods Pharmaceuticals
  • Lupin
  • Jubilant Pharma
  • HETERO
  • Aurobindo Pharma
  • Amneal Pharmaceuticals
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Valsartan Drug Market by Type
  3. 1.2.1 Global Valsartan Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 40 mg Tablets
  5. 1.2.3 80 mg Tablets
  6. 1.2.4 160 mg Tablets
  7. 1.2.5 320 mg Tablets
  8. 1.3 Valsartan Drug Market by Application
  9. 1.3.1 Global Valsartan Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Heart Failure
  11. 1.3.3 Heart Attack
  12. 1.3.4 Hypertension
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Valsartan Drug Market Dynamics
  1. 2.1 Valsartan Drug Industry Trends
  2. 2.2 Valsartan Drug Industry Drivers
  3. 2.3 Valsartan Drug Industry Opportunities and Challenges
  4. 2.4 Valsartan Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Valsartan Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Valsartan Drug Revenue by Region
  3. 3.2.1 Global Valsartan Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Valsartan Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Valsartan Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Valsartan Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Valsartan Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Valsartan Drug Sales by Region
  9. 3.4.1 Global Valsartan Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Valsartan Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Valsartan Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Valsartan Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Valsartan Drug Revenue by Manufacturers
  2. 4.1.1 Global Valsartan Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Valsartan Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Valsartan Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Valsartan Drug Sales by Manufacturers
  6. 4.2.1 Global Valsartan Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Valsartan Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Valsartan Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Valsartan Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Valsartan Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Valsartan Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Valsartan Drug Manufacturers, Product Type & Application
  13. 4.7 Global Valsartan Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Valsartan Drug Market CR5 and HHI
  16. 4.8.2 2025 Valsartan Drug Tier 1, Tier 2, and Tier 3
5 Valsartan Drug Market by Type
  1. 5.1 Global Valsartan Drug Revenue by Type
  2. 5.1.1 Global Valsartan Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Valsartan Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Valsartan Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Valsartan Drug Sales by Type
  6. 5.2.1 Global Valsartan Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valsartan Drug Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Valsartan Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Valsartan Drug Price by Type
6 Valsartan Drug Market by Application
  1. 6.1 Global Valsartan Drug Revenue by Application
  2. 6.1.1 Global Valsartan Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Valsartan Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Valsartan Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Valsartan Drug Sales by Application
  6. 6.2.1 Global Valsartan Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Valsartan Drug Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Valsartan Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Valsartan Drug Price by Application
7 Company Profiles
  1. 7.1 Zhejiang Huahai Pharmaceutical
  2. 7.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 7.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 7.1.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolio
  6. 7.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Valsartan Drug Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Sun Pharmaceutical
  14. 7.3.1 Sun Pharmaceutical Company Information
  15. 7.3.2 Sun Pharmaceutical Business Overview
  16. 7.3.3 Sun Pharmaceutical Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharmaceutical Valsartan Drug Product Portfolio
  18. 7.3.5 Sun Pharmaceutical Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Valsartan Drug Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Valsartan Drug Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 Huaren Pharmaceutical
  32. 7.6.1 Huaren Pharmaceutical Company Information
  33. 7.6.2 Huaren Pharmaceutical Business Overview
  34. 7.6.3 Huaren Pharmaceutical Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Huaren Pharmaceutical Valsartan Drug Product Portfolio
  36. 7.6.5 Huaren Pharmaceutical Recent Developments
  37. 7.7 Unichem Laboratories
  38. 7.7.1 Unichem Laboratories Company Information
  39. 7.7.2 Unichem Laboratories Business Overview
  40. 7.7.3 Unichem Laboratories Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Unichem Laboratories Valsartan Drug Product Portfolio
  42. 7.7.5 Unichem Laboratories Recent Developments
  43. 7.8 Torrent Pharmaceuticals
  44. 7.8.1 Torrent Pharmaceuticals Company Information
  45. 7.8.2 Torrent Pharmaceuticals Business Overview
  46. 7.8.3 Torrent Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Torrent Pharmaceuticals Valsartan Drug Product Portfolio
  48. 7.8.5 Torrent Pharmaceuticals Recent Developments
  49. 7.9 Square Pharmaceuticals
  50. 7.9.1 Square Pharmaceuticals Company Information
  51. 7.9.2 Square Pharmaceuticals Business Overview
  52. 7.9.3 Square Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Square Pharmaceuticals Valsartan Drug Product Portfolio
  54. 7.9.5 Square Pharmaceuticals Recent Developments
  55. 7.10 Macleods Pharmaceuticals
  56. 7.10.1 Macleods Pharmaceuticals Company Information
  57. 7.10.2 Macleods Pharmaceuticals Business Overview
  58. 7.10.3 Macleods Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Macleods Pharmaceuticals Valsartan Drug Product Portfolio
  60. 7.10.5 Macleods Pharmaceuticals Recent Developments
  61. 7.11 Lupin
  62. 7.11.1 Lupin Company Information
  63. 7.11.2 Lupin Business Overview
  64. 7.11.3 Lupin Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Lupin Valsartan Drug Product Portfolio
  66. 7.11.5 Lupin Recent Developments
  67. 7.12 Jubilant Pharma
  68. 7.12.1 Jubilant Pharma Company Information
  69. 7.12.2 Jubilant Pharma Business Overview
  70. 7.12.3 Jubilant Pharma Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Jubilant Pharma Valsartan Drug Product Portfolio
  72. 7.12.5 Jubilant Pharma Recent Developments
  73. 7.13 HETERO
  74. 7.13.1 HETERO Company Information
  75. 7.13.2 HETERO Business Overview
  76. 7.13.3 HETERO Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 HETERO Valsartan Drug Product Portfolio
  78. 7.13.5 HETERO Recent Developments
  79. 7.14 Aurobindo Pharma
  80. 7.14.1 Aurobindo Pharma Company Information
  81. 7.14.2 Aurobindo Pharma Business Overview
  82. 7.14.3 Aurobindo Pharma Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Aurobindo Pharma Valsartan Drug Product Portfolio
  84. 7.14.5 Aurobindo Pharma Recent Developments
  85. 7.15 Amneal Pharmaceuticals
  86. 7.15.1 Amneal Pharmaceuticals Company Information
  87. 7.15.2 Amneal Pharmaceuticals Business Overview
  88. 7.15.3 Amneal Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Amneal Pharmaceuticals Valsartan Drug Product Portfolio
  90. 7.15.5 Amneal Pharmaceuticals Recent Developments
  91. 7.16 Alembic Pharmaceuticals
  92. 7.16.1 Alembic Pharmaceuticals Company Information
  93. 7.16.2 Alembic Pharmaceuticals Business Overview
  94. 7.16.3 Alembic Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Alembic Pharmaceuticals Valsartan Drug Product Portfolio
  96. 7.16.5 Alembic Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Valsartan Drug Market Size by Type
  2. 8.1.1 North America Valsartan Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Valsartan Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Valsartan Drug Price by Type (2021-2032)
  5. 8.2 North America Valsartan Drug Market Size by Application
  6. 8.2.1 North America Valsartan Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Valsartan Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Valsartan Drug Price by Application (2021-2032)
  9. 8.3 North America Valsartan Drug Market Size by Country
  10. 8.3.1 North America Valsartan Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Valsartan Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Valsartan Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Valsartan Drug Market Size by Type
  2. 9.1.1 Europe Valsartan Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Valsartan Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Valsartan Drug Price by Type (2021-2032)
  5. 9.2 Europe Valsartan Drug Market Size by Application
  6. 9.2.1 Europe Valsartan Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Valsartan Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Valsartan Drug Price by Application (2021-2032)
  9. 9.3 Europe Valsartan Drug Market Size by Country
  10. 9.3.1 Europe Valsartan Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Valsartan Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Valsartan Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Valsartan Drug Market Size by Type
  2. 10.1.1 China Valsartan Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Valsartan Drug Sales by Type (2021-2032)
  4. 10.1.3 China Valsartan Drug Price by Type (2021-2032)
  5. 10.2 China Valsartan Drug Market Size by Application
  6. 10.2.1 China Valsartan Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Valsartan Drug Sales by Application (2021-2032)
  8. 10.2.3 China Valsartan Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Valsartan Drug Market Size by Type
  2. 11.1.1 Asia Valsartan Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Valsartan Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Valsartan Drug Price by Type (2021-2032)
  5. 11.2 Asia Valsartan Drug Market Size by Application
  6. 11.2.1 Asia Valsartan Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Valsartan Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Valsartan Drug Price by Application (2021-2032)
  9. 11.3 Asia Valsartan Drug Market Size by Country
  10. 11.3.1 Asia Valsartan Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Valsartan Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Valsartan Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Valsartan Drug Market Size by Type
  2. 12.1.1 SAMEA Valsartan Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Valsartan Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Valsartan Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Valsartan Drug Market Size by Application
  6. 12.2.1 SAMEA Valsartan Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Valsartan Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Valsartan Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Valsartan Drug Market Size by Country
  10. 12.3.1 SAMEA Valsartan Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Valsartan Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Valsartan Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Valsartan Drug Value Chain Analysis
  2. 13.1.1 Valsartan Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Valsartan Drug Production Mode & Process
  6. 13.2 Valsartan Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Valsartan Drug Distributors
  9. 13.2.3 Valsartan Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst